[1]
Úlusarczyk, A. 2025. Solifenacin in the treatment of overactive bladder syndrome: efficacy, safety and the relevance of clinical diagnosis. Medycyna Faktow (J EBM). 18, 2(67) (Jun. 2025), 283-287. DOI:https://doi.org/10.24292/01.MF.0225.17.